(Hypertension. 1999;33:1190-1194.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
Estradiol With or Without Progesterone and Ambulatory Blood Pressure in Postmenopausal Women
From the Departments of Medicine [Endocrine-Hypertension (E.W.S., G.H.W.) and Cardiovascular (M.D.G.) Divisions] (E.W.S.) and Obstetrics and Gynecology (B.W.W.), Brigham and Women's Hospital and Harvard Medical School, Boston, Mass.
Correspondence to Ellen W. Seely, MD, Brigham and Women's Hospital, Endocrine-Hypertension Division, 221 Longwood Ave, Boston, MA 02115. E-mail ewseely{at}bics.bwh.harvard.edu
Abstract—The purpose of this study was to determine whether transdermal estradiol and intravaginal progesterone given in doses to mimic the premenopausal state would lower blood pressure (BP) in postmenopausal women. Fifteen healthy postmenopausal women were studied in each of 3 conditions: on placebo, after 8 weeks of transdermal estradiol 0.2 mg twice per week, and again 2 weeks after addition of intravaginal progesterone 300 mg/d. Women were studied at each point after 2 days of 100 mmol/d sodium intake. Twenty-four–hour ambulatory BP monitoring was performed, and blood was assayed for estradiol, progesterone, and hormones of the renin-angiotensin-aldosterone system (RAAS). ANOVA with pairwise comparisons was used for analysis. Urinary sodium excretion was similar at each time point. Levels of estrogen and progesterone similar to those in premenopausal women were achieved. On estradiol, nocturnal systolic BP (110±3 mm Hg), diastolic BP (63±2 mm Hg), and mean BP (77±2 mm Hg) fell significantly (P<0.02) compared with placebo systolic BP (116±2 mm Hg), diastolic BP (68±2 mm Hg), and mean BP (82±2 mm Hg). Daytime BP followed the same trend but was significantly lower only for mean BP. There was no activation of the RAAS. The addition of progesterone resulted in no further fall in BP but a significant activation of the RAAS. Thus, contrary to what is often assumed, administration of estradiol with or without progesterone not only did not raise BP but rather substantially lowered BP. This BP-lowering effect may be responsible for the lower incidence of hypertension in premenopausal than in postmenopausal women.
Key Words: hypertension • women • blood pressure monitoring, ambulatory • renin-angiotensin system
This article has been cited by other articles:
 |
|
 |
|
  J. L. Rogers, A. R. Mitchell, C. Maric, K. Sandberg, A. Myers, and S. E. Mulroney Effect of sex hormones on renal estrogen and angiotensin type 1 receptors in female and male rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R794 - R799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J Fadel, Z. Wang, H. Watanabe, D. Arbique, W. Vongpatanasin, and G. D Thomas Augmented sympathetic vasoconstriction in exercising forearms of postmenopausal women is reversed by oestrogen therapy J. Physiol., December 15, 2004; 561(3): 893 - 901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Head, V. R. Obeyesekere, M. E. Jones, E. R. Simpson, and Z. S. Krozowski Aromatase-Deficient (ArKO) Mice Have Reduced Blood Pressure and Baroreflex Sensitivity Endocrinology, September 1, 2004; 145(9): 4286 - 4291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Reckelhoff and L. A. Fortepiani Novel Mechanisms Responsible for Postmenopausal Hypertension Hypertension, May 1, 2004; 43(5): 918 - 923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Nakano, T. Oshima, R. Ozono, A. Ueda, Y. Oue, H. Matsuura, M. Sanada, K. Ohama, K. Chayama, and M. Kambe Estrogen replacement suppresses function of thrombin stimulated platelets by inhibiting Ca2+ influx and raising cyclic adenosine monophosphate Cardiovasc Res, February 15, 2002; 53(3): 634 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Dubey, S. Oparil, B. Imthurn, and E. K. Jackson Sex hormones and hypertension Cardiovasc Res, February 15, 2002; 53(3): 688 - 708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Simaan, C. Cadorette, M. Poterek, J. St-Louis, and M. Brochu Calcium channels contribute to the decrease in blood pressure of pregnant rats Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H665 - H671. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Scuteri, A. J.G. Bos, L. J. Brant, L. Talbot, E. G. Lakatta, and J. L. Fleg Hormone Replacement Therapy and Longitudinal Changes in Blood Pressure in Postmenopausal Women Ann Intern Med, August 21, 2001; 135(4): 229 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tsuda, Y. Kinoshita, K. Kimura, I. Nishio, and Y. Masuyama Electron Paramagnetic Resonance Investigation on Modulatory Effect of 17{beta}-Estradiol on Membrane Fluidity of Erythrocytes in Postmenopausal Women Arterioscler. Thromb. Vasc. Biol., August 1, 2001; 21(8): 1306 - 1312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Vongpatanasin, M. Tuncel, Y. Mansour, D. Arbique, and R. G. Victor Transdermal Estrogen Replacement Therapy Decreases Sympathetic Activity in Postmenopausal Women Circulation, June 19, 2001; 103(24): 2903 - 2908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Reckelhoff Gender Differences in the Regulation of Blood Pressure Hypertension, May 1, 2001; 37(5): 1199 - 1208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Aviv Hypothesis : Pulse Pressure and Human Longevity Hypertension, April 1, 2001; 37(4): 1060 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. V. Dantas, R. Scivoletto, Z. B. Fortes, D. Nigro, and M. H. C. Carvalho Influence of Female Sex Hormones on Endothelium-Derived Vasoconstrictor Prostanoid Generation in Microvessels of Spontaneously Hypertensive Rats Hypertension, October 1, 1999; 34(4): 914 - 919. [Abstract] [Full Text] [PDF]
|
|